customer service software
0

Metabolomics: Technologies and Global Markets

  • Published Date: 12 Feb 2019
  • Number of Pages: 222
  • Category: Technology
  • Country: Global
Summary

The global metabolomics market is expected to reach about REDACTED by 2023, increasing at a compound annual growth rate (CAGR) of REDACTED from 2018 through 2023. The major drivers of market growth are increasing investment in metabolomic research through public and private funding, increasing applications of metabolomics in personalized medicine, increasing R&D funding for pharmaceutical and biotech companies and increasing technological advancements in this market arena. However, the shortage of qualified technicians, high cost of tools and instruments, and the complexity associated with metabolomic data examination and processing pose threats to market growth.

Based on products, the separation technique market accounted for REDACTED of the global metabolomics market in 2017. However, the bioinformatic market is expected grow at the highest CAGR of REDACTED during the forecast period of 2018 to 2023. High growth in this application segment is mainly attributed to the increasing usage of different bioinformatic platforms in various metabolomic applications such as drug discovery and development and the benefit of smooth technological workflow with the precise,reliable and transparent data processing benefits gained from it.

The geographic analysis reveals that North America dominated the market in 2017, accounting for the largest share, REDACTED, of the global metabolomics market. This market is projected to reach REDACTED billion by 2023 from REDACTED in 2018, at a CAGR of REDACTED during the forecast period. The dominance of North America is justified by the presence of a wide pool of market players offering their products in the metabolomics market. These companies include Agilent Technologies Inc., Bio-Rad Laboratories, BrukerCorp., Danaher Corp., Human Metabolome Technologies Inc., LECO Corp., Metabolon Inc., Shimadzu Corp., Thermo Fisher Scientific Inc. and Waters Corp., among others.

In addition, easy availability of technologically advanced products and significant investments in metabolomic-based research in drug discovery studies, personalized medicine and cancer therapeutics will also drive the North American market during the forecast period. For instance, as of 2017, the United States Congress has increased its budget for medical research by allocating REDACTED to medical research at the National Institutes of Health (NIH). Also, Congress has increased cancer research funding to about REDACTED. However, the market for metabolomics in the Asia-Pacific region is expected to grow at the highest CAGR of REDACTED during the forecast period. Asia-Pacifics high growth rate is
attributed to unmet healthcare needs, high prevalence of cancer, high investments in metabolomic-based research, improving pharmaceutical research infrastructure and growing R&D funding for cancer drug discovery and personalized medicine opportunities.
Publisher Name : BCC Research

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Methodology and Information Sources
Secondary Research
Primary Research
Market Size Estimation
Data Triangulation
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Market Context for Metabolomics
Chapter 3 Overview of Metabolomics
Introduction
Metabolites
Metabolomics
Metabolomic History
Metabolic Pathways
Metabolomes
Large Bowel Microflora
Urine Metabolome
Food Metabolome
Lipidomes and Lipidomics
Fluxomics
Metabolomic Process Steps
Sample Preparation
Extraction
Derivatization
Separation and Detection
Data Analysis
Metabolomic Technology
Targeted and Untargeted Approaches
Applications
Chapter 4 Metabolomics Market Dynamics
Metabolomics Market Drivers
Increasing Investment in Metabolomic Research
Increase in Demand for Personalized Medicine
Increasing Pharmaceutical and Biotech R&D Spending
Technological Advancements
Increasing Use of Metabolomics in Toxicology Testing
Market Restraints
Complexity Associated with Data Examination and Processing
High Cost of Tools and Instruments
Key Market Opportunities
Rapid Growth Opportunities in Emerging Markets
Key Challenges
Complexity and Diversity of Biological Samples
Dearth of Skilled Researchers
Industry Insights
Market Trends
Chapter 5 Global Metabolomics Market Breakdown by Product
Introduction
Market Breakdown
Separation Techniques
Detection Techniques
Assays
Bioinformatics and Systems Biology Tools
Chapter 6 Global Metabolomics Market Breakdown by Indication
Introduction
Market Breakdown
Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Chapter 7 Global Metabolomics Market Breakdown by Application
Introduction
Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Chapter 8 Global Metabolomics Market Breakdown by Geography
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
Latin America
Middle East and Africa (MEA)
Chapter 9 Competitive Analysis
Market Overview
Metabolomics Market Share Analysis
Product Portfolio Assessment
Competitive Situations and Trends
Chapter 10 Company Profiles
ABCAM PLC
AGILENT TECHNOLOGIES INC.
BG MEDICINE INC.
BIO-RAD LABORATORIES INC.
BIOCRATES AG
BIOVISION INC.
BRUKER CORP.
CALITHERA BIOSCIENCES INC.
CHENOMX
CITOXLAB
CLEVELAND HEARTLAB INC.
CYPROTEX PLC (PART OF EVOTEC)
DANAHER CORP.
DRUMETIX LABORATORIES LLC
EXALENZ BIOSCIENCE LTD.
GENOMIND, INC.
GERSTEL GMBH & CO. KG
HEPATOCHEM
HUMAN METABOLOME TECHNOLOGIES AMERICA INC.
LECO CORP.
LUMINEX CORP.
MERCK KGAA
METABOLOMIC DIAGNOSTICS
METABOLOMIC TECHNOLOGIES INC.
METABOLOMX
METABOLON INC.
ONE WAY LIVER GENOMICS, S.L
PERKINELMER INC.
PROMEGA CORP.
QIAGEN GMBH
SHIMADZU CORP.
STEMINA BIOMARKER DISCOVERY INC.
THERMO FISHER SCIENTIFIC INC.
TSI INC.
WATERS CORP.
Chapter 11 Acronyms

List Of Tables


Summary Table : Global Market for Metabolomics, by Product Type, Through 2023
Table 1 : Publications Referencing Metabolomics, 2008-2018
Table 2 : Human Metabolome Project and Database, 2015-2018
Table 3 : Major Approaches in Metabolomics and their Advantages and Disadvantages
Table 4 : Recent Funding Programs in Metabolomics
Table 5 : Common Hyphenated Platforms in Metabolomic Research
Table 6 : Global Market for Metabolomics, by Product Type, Through 2023
Table 7 : Global Market for Metabolomics, by Region, Through 2023
Table 8 : Global Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 9 : Global Market for Separation Techniques Applied in Metabolomics, by Region, Through 2023
Table 10 : Global Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 11 : Global Market for Liquid Chromatography Applied in Metabolomics, by Region, Through 2023
Table 12 : Global Market for High-Performance Liquid Chromatography Applied in Metabolomics, by Region, Through 2023
Table 13 : Global Market for UPLC Applied in Metabolomics, by Region, Through 2023
Table 14 : Global Market for Gas Chromatography Applied in Metabolomics, by Region, Through 2023
Table 15 : Global Market for Capillary Electrophoresis Applied in Metabolomics, by Region, Through 2023
Table 16 : Global Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 17 : Global Market for Detection Techniques Applied in Metabolomics, by Region, Through 2023
Table 18 : Leading Mass Spectroscopy Suppliers for the Life Sciences
Table 19 : Leading Mass Spectroscopy Systems
Table 20 : Global Market for Mass Spectrometry Applied in Metabolomics, by Region, Through 2023
Table 21 : Global Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 22 : Global Market for Spectroscopy Applied in Metabolomics, by Region, Through 2023
Table 23 : Global Market for NMR Spectroscopy Applied in Metabolomics, by Region, Through 2023
Table 24 : Global Market for Metabolomic Assays, by Product Type, Through 2023
Table 25 : Global Market for Metabolomic Assays, by Region, Through 2023
Table 26 : High-Content Screening Suppliers and Key Attributes
Table 27 : Label-Free Technologies and Suppliers
Table 28 : Major Categories of Assays Used in Metabolomics for Drug Discovery
Table 29 : Assays Commonly Used with Metabolomic Assays
Table 30 : In Vitro and In Vivo Assay Tests in Tier 1 Screening Battery
Table 31 : Metabolomic Open-Access Data Processing Tools
Table 32 : Metabolomic Public Resources
Table 33 : Other Metabolomic Bioinformatic Resources
Table 34 : Global Market for the Application of Bioinformatics in Metabolomics, by Region, Through 2023
Table 35 : Global Market for Metabolomics, by Indication, Through 2023
Table 36 : Global Market for the Application of Metabolomics in Cancer Indications, by Region, Through 2023
Table 37 : Global Market for the Application of Metabolomics in Cardiovascular Disorders, by Region, Through 2023
Table 38 : Representation of Pathways, Functions of Metabolites and Possible Biomarkers in Animal Model and Human-Based Studies of Various Neuropsychiatric Disorders
Table 39 : Global Market for the Application of Metabolomics in Neurological Disorders, by Region, Through 2023
Table 40 : Global Market for the Application of Metabolomics in Inborn Errors of Metabolism, by Region, Through 2023
Table 41 : Global Market for Metabolomics, by Application, Through 2023
Table 42 : Global Market for Biomarker Discovery, by Region, Through 2023
Table 43 : Global Market for the Application of Metabolomics in Drug Discovery, by Region, Through 2023
Table 44 : Global Market for the Application of Metabolomics in Toxicology Testing, by Region, Through 2023
Table 45 : Global Market for the Application of Metabolomics in Nutrigenomics, by Region, Through 2023
Table 46 : Global Market for the Application of Metabolomics in Functional Genomics, by Region, Through 2023
Table 47 : Global Market for Metabolomics, by Region, Through 2023
Table 48 : North American Market for Metabolomics, by Product Type, Through 2023
Table 49 : North American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 50 : North American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 51 : North American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 52 : North American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 53 : North American Market for Metabolomics, by Indication, Through 2023
Table 54 : North American Market for Metabolomics, by Application, Through 2023
Table 55 : North American Market for Spectroscopy Applied in Metabolomic Assays, by Product Type, Through 2023
Table 56 : European Market for Metabolomics, by Product Type, Through 2023
Table 57 : European Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 58 : European Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 59 : European Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 60 : European Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 61 : European Market for Metabolomic Assays, by Product Type, Through 2023
Table 62 : European Market for Metabolomics, by Indication, Through 2023
Table 63 : European Market for Metabolomics, by Application, Through 2023
Table 64 : Asia-Pacific Market for Metabolomics, by Product Type, Through 2023
Table 65 : Asia-Pacific Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 66 : Asia-Pacific Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 67 : Asia-Pacific Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 68 : Asia-Pacific Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 69 : Asia-Pacific Market for Metabolomic Assays, by Product Type, Through 2023
Table 70 : Asia-Pacific Market for Metabolomics, by Indication, Through 2023
Table 71 : Asia-Pacific Market for Metabolomics, by Application, Through 2023
Table 72 : Latin American Market for Metabolomics, by Product Type, Through 2023
Table 73 : Latin American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 74 : Latin American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 75 : Latin American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 76 : Latin American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 77 : Latin American Market for Metabolomic Assays, by Product Type, Through 2023
Table 78 : Latin American Market for Metabolomics, by Indication, Through 2023
Table 79 : Latin American Market for Metabolomics, by Application, Through 2023
Table 80 : Middle East and African Market for Metabolomics, by Product Type, Through 2023
Table 81 : Middle East and African Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 82 : Middle East and African Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2023
Table 83 : Middle-East and African Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2023
Table 84 : Middle East and African Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2023
Table 85 : Middle East and African Market for Metabolomic Assays, by Product Type, Through 2023
Table 86 : Middle East and African Market for Metabolomics, by Indication, Through 2023
Table 87 : Middle East and African Market for Metabolomics, by Application, Through 2023
Table 88 : Manufacturers and Suppliers of Metabolomic Products, by Category, 2017
Table 89 : Recent Developments in the Metabolomics Industry, January 2017 through December 2018
Table 90 : Abcam Plc: Recent Financials, 2017 and 2018
Table 91 : Agilent Technologies: Recent Financials, 2016 and 2017
Table 92 : Bio-Rad Laboratories: Recent Financials, 2016 and 2017
Table 93 : Bruker Corp.: Recent Financials, 2016 and 2017
Table 94 : Calithera Biosciences: Recent Financials, 2016 and 2017
Table 95 : Evotec: Recent Financials, 2016 and 2017
Table 96 : Danaher Corp.: Recent Financials, 2016 and 2017
Table 97 : Luminex Corp.: Recent Financials, 2016 and 2017
Table 98 : Merck KGaA: Recent Financials, 2016 and 2017
Table 99 : Qiagen N.V.: Recent Financials, 2016 and 2017
Table 100 : Thermo Fisher Scientific: Recent Financials, 2016 and 2017
Table 101 : Waters Corp.: Recent Financials, 2016 and 2017
Table 102 : Important Acronyms Related to Metabolomics Used in This Report

List Of Figures


Summary Figure : Global Market Share for Metabolomics, by Product Type, 2018 and 2023
Figure 1 : Publications Referencing Metabolomics, 2008-2018
Figure 2 : Cellular Respiration Stages
Figure 3 : Factors Impacting Enzyme Activity
Figure 4 : Typical Analytical Metabolomic Process Steps
Figure 5 : Schematic Representation of a Metabolomic Workflow
Figure 6 : Performance of Common Hyphenated MS Platforms
Figure 7 : Bioinformatic Processes for Metabolomics
Figure 8 : Cumulative Revenues of Biotechnology Companies, 2010-2017
Figure 9 : Manufacturer and Supplier Market Share of Metabolomics, 2017
Figure 10 : Abcam Plc: Recent Financials, 2017 and 2018
Figure 11 : Abcam Plc: Revenue Share, by Product and Service, 2018
Figure 12 : Abcam Plc: Revenue Share, by Region/Country, 2018
Figure 13 : Agilent Technologies: Recent Financials, 2016 and 2017
Figure 14 : Agilent Technologies: Revenue Share, by Business Segment, 2017
Figure 15 : Agilent Technologies: Revenue Share, by Region/Country, 2017
Figure 16 : Bio-Rad Laboratories: Recent Financials, 2016 and 2017
Figure 17 : Bio-Rad Laboratories: Revenue Share, by Business Segment, 2017
Figure 18 : Bio-Rad Laboratories: Revenue Share, by Region/Country, 2017
Figure 19 : Bruker Corp.: Recent Financials, 2016 and 2017
Figure 20 : Bruker Corp.: Revenue Share, by Business Segment, 2017
Figure 21 : Bruker Corp.: Revenue Share, by Region/Country, 2017
Figure 22 : Calithera Biosciences: Revenue Share and Financials, 2016 and 2017
Figure 23 : Evotec: Recent Financials, 2016 and 2017
Figure 24 : Evotec: Revenue Share, by Business Segment, 2017
Figure 25 : Evotec: Revenue Share, by Region/Country, 2017
Figure 26 : Danaher Corp.: Recent Financials, 2016 and 2017
Figure 27 : Danaher Corp.: Revenue Share, by Business Segment, 2017
Figure 28 : Danaher Corp.: Revenue Share, by Region/Country, 2017
Figure 29 : Luminex Corp.: Recent Financials, 2016 and 2017
Figure 30 : Luminex Corp.: Revenue Share, by Region/Country, 2017
Figure 31 : Merck KGaA: Recent Financials, 2016 and 2017
Figure 32 : Merck KGaA: Revenue Share, by Business Segment, 2017
Figure 33 : Merck KGaA: Revenue Share, by Region, 2017
Figure 34 : PerkinElmer: Revenue Share, by Business Segment, 2017
Figure 35 : PerkinElmer: Revenue Share, by Region/Country, 2017
Figure 36 : Qiagen N.V.: Recent Financials, 2016 and 2017
Figure 37 : Qiagen N.V.: Revenue Share, by Segment, 2017
Figure 38 : Qiagen N.V.: Revenue Share, by Region, 2017
Figure 39 : Thermo Fisher Scientific: Recent Financials, 2016 and 2017
Figure 40 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2017
Figure 41 : Thermo Fisher Scientific: Revenue Share, by Region/Country, 2017
Figure 42 : Waters Corp.: Recent Financials, 2016 and 2017
Figure 43 : Waters Corp.: Revenue Share, by Business Segment, 2017
Figure 44 : Waters Corp.: Revenue Share, by Region/Country, 2017

Disruptor Profile: Flotek Industries Flotek Industries develops Energy Chemistry Technologies (ECT) to help oil and gas clients address key challenges in the lifecycle of oil wells and maximize the oil recovery

View Report

Enterprise Tech Ecosystem Series: Moet Hennessy Louis Vuitton SE Moet Hennessy Louis Vuitton SE (LVMH), headquartered at Paris, France, is a renowned manufacturer and marketer of luxury goods. Its product portfolio

View Report

Disruptor Profile: Grid Singularity Grid Singularity is a green blockchain technology company that designs and develops open, decentralized energy data exchange platform based on blockchain technology, in association with Energy Web

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports